1AI Approval granted for group 3 in Parkinsons trial 08/02/17 PRICE SENSITIVE download Created with Sketch. 332.69KB Share 1AI Appendix 4C - quarterly 20/01/17 PRICE SENSITIVE download Created with Sketch. 650.09KB Share 1AI US choroid plexus cells patent application published 11/01/17 PRICE SENSITIVE download Created with Sketch. 88.79KB Share 1AI Group 2 Parkinsons trial patients treatment completed 22/12/16 PRICE SENSITIVE download Created with Sketch. 88.22KB Share 1AI Reinstatement to Official Quotation 30/11/16 PRICE SENSITIVE download Created with Sketch. 232.05KB Share 1AI Private Placement 30/11/16 PRICE SENSITIVE download Created with Sketch. 437.34KB Share 1AI Suspension from Official Quotation 28/11/16 PRICE SENSITIVE download Created with Sketch. 331.96KB Share 1AI Trading Halt 24/11/16 PRICE SENSITIVE download Created with Sketch. 497.23KB Share 1AI Approval granted for group 2 in Parkinsons trial 11/11/16 PRICE SENSITIVE download Created with Sketch. 333.64KB Share 1AI Appendix 4C Quarterly Cash Flow Report 30 September 2016-LCT.AX 20/10/16 PRICE SENSITIVE download Created with Sketch. 623.51KB Share 1AI Group 1 patients successfully treated in Parkinsons trial-LCT.AX 05/10/16 PRICE SENSITIVE download Created with Sketch. 334.12KB Share 1AI Preliminary Final Report and Financial Statements-LCT.AX 24/08/16 PRICE SENSITIVE download Created with Sketch. 1.8MB Share 1AI LCT's joint venture focuses on US developments-LCT.AX 22/08/16 PRICE SENSITIVE download Created with Sketch. 321.01KB Share 1AI Response to ASX Price Query-LCT.AX 17/08/16 PRICE SENSITIVE download Created with Sketch. 504.36KB Share 1AI Appendix 4C - quarterly-LCT.AX 28/07/16 PRICE SENSITIVE download Created with Sketch. 589.86KB Share 1AI Response to ASX Price Query-LCT.AX 22/06/16 PRICE SENSITIVE download Created with Sketch. 249.63KB Share 1AI NTCELL demonstrates continued reversal of Parkinsons-LCT.AX 07/06/16 PRICE SENSITIVE download Created with Sketch. 390.84KB Share 1AI Appendix 4C - quarterly-LCT.AX 14/04/16 PRICE SENSITIVE download Created with Sketch. 572.24KB Share 1AI LCT starts Phase IIb clinical trial of NTCELL 24/03/16 PRICE SENSITIVE download Created with Sketch. 332.92KB Share 1AI Half Yearly Report and Accounts 26/02/16 PRICE SENSITIVE download Created with Sketch. 776.28KB Share 1AI LCT completes $2.8m private placement and announces SPP 17/02/16 PRICE SENSITIVE download Created with Sketch. 81.11KB Share 1AI LCT receives ethics approval for Phase IIb Parkinsons trial 03/02/16 PRICE SENSITIVE download Created with Sketch. 76.41KB Share 1AI NTCELL reverses the progression of Parkinsons disease 27/01/16 PRICE SENSITIVE download Created with Sketch. 87.35KB Share 1AI Commentary on Appendix 4C - 31 December 2015 12/01/16 PRICE SENSITIVE download Created with Sketch. 72.11KB Share 1AI Appendix 4C - quarterly 12/01/16 PRICE SENSITIVE download Created with Sketch. 97.39KB Share 1AI LCT complies with ASIC infringement notice 18/12/15 PRICE SENSITIVE download Created with Sketch. 51.91KB Share 1AI LCT secures supply of NTCELL 02/12/15 PRICE SENSITIVE download Created with Sketch. 48.3KB Share 1AI Update on clinical trials of encapsulated pig islets 16/11/15 PRICE SENSITIVE download Created with Sketch. 3.18MB Share 1AI Minister authorises Phase IIb Parkinson's study 12/11/15 PRICE SENSITIVE download Created with Sketch. 50.17KB Share 1AI NTCELL - Parkinson's trial 42 week result 27/10/15 PRICE SENSITIVE download Created with Sketch. 49.06KB Share 1AI Appendix 4C - quarterly 14/10/15 PRICE SENSITIVE download Created with Sketch. 51.13KB Share 1AI LCT to receive Callaghan Innovation Growth Grant 28/08/15 PRICE SENSITIVE download Created with Sketch. 49.23KB Share 1AI Appendix 4E and Financial Statements YE 30 June 2015 19/08/15 PRICE SENSITIVE download Created with Sketch. 670.18KB Share 1AI LCT planning to resume control of NTCELL manufacture 18/08/15 PRICE SENSITIVE download Created with Sketch. 48.75KB Share 1AI Response to ASX aware letter 29/07/15 PRICE SENSITIVE download Created with Sketch. 385.73KB Share 1AI Appendix 4C - quarterly 27/07/15 PRICE SENSITIVE download Created with Sketch. 493.17KB Share 1AI Update to DIABECELL development strategy 26/06/15 PRICE SENSITIVE download Created with Sketch. 49.36KB Share 1AI NTCELL Clinical Study in Parkinson's Meets Endpoints 15/06/15 PRICE SENSITIVE download Created with Sketch. 31.09KB Share 1AI Trading Halt 12/06/15 PRICE SENSITIVE download Created with Sketch. 49.25KB Share 1AI LCT JV adopts new strategy for DIABECELL 05/03/15 PRICE SENSITIVE download Created with Sketch. 39.07KB Share 1AI Half Yearly Report and Accounts 18/02/15 PRICE SENSITIVE download Created with Sketch. 338.53KB Share 1AI Appendix 4C - quarterly 28/01/15 PRICE SENSITIVE download Created with Sketch. 100.74KB Share 1AI LCT completes patient implants in Parkinson's trial 15/12/14 PRICE SENSITIVE download Created with Sketch. 21.96KB Share 1AI Appendix 4C 30 Sep 2014 28/10/14 PRICE SENSITIVE download Created with Sketch. 96.33KB Share 1AI LCT JV secures funds to realise the potential of DIABECELL 10/10/14 PRICE SENSITIVE download Created with Sketch. 62.18KB Share 1AI Completion of $3m placement and SPP announced 08/10/14 PRICE SENSITIVE download Created with Sketch. 279.03KB Share 1AI Successful second implant of NTCELL for Parkinson's 18/08/14 PRICE SENSITIVE download Created with Sketch. 48.63KB Share 1AI Appendix 4E and Financial Statements 15/08/14 PRICE SENSITIVE download Created with Sketch. 481.12KB Share 1AI Appendix 4C - quarterly 30/07/14 PRICE SENSITIVE download Created with Sketch. 51.17KB Share 1AI Dr Ken Taylor appointed Chief Executive 08/07/14 PRICE SENSITIVE download Created with Sketch. 66.12KB Share 1AI LCT Parkinson's trial resumes patient recruitment 23/06/14 PRICE SENSITIVE download Created with Sketch. 62KB Share 1AI LCT to develop NTCELL independently 15/05/14 PRICE SENSITIVE download Created with Sketch. 61.96KB Share 1AI Appendix 4C - quarterly 29/04/14 PRICE SENSITIVE download Created with Sketch. 101.25KB Share 1AI LCT restructures 01/04/14 PRICE SENSITIVE download Created with Sketch. 273.88KB Share 1AI Appendix 4D and Half Year Financial Report 25/02/14 PRICE SENSITIVE download Created with Sketch. 313.69KB Share 1AI Appendix 4C - quarterly 29/01/14 PRICE SENSITIVE download Created with Sketch. 51.26KB Share 1AI Withdrawal of NTCELL pre-clinical study 19/12/13 PRICE SENSITIVE download Created with Sketch. 276.5KB Share 1AI Response to ASX Aware Query 04/12/13 PRICE SENSITIVE download Created with Sketch. 155.84KB Share 1AI NTCELL clinical trial - Further patients approved 25/11/13 PRICE SENSITIVE download Created with Sketch. 94.64KB Share 1AI Saftey and efficacy findings of DIA 09 study of DIABECELL 01/11/13 PRICE SENSITIVE download Created with Sketch. 291.91KB Share 1AI Appendix 4C - quarterly 30/10/13 PRICE SENSITIVE download Created with Sketch. 493.4KB Share 1AI First patient successfully implanted with NTCELL 20/09/13 PRICE SENSITIVE download Created with Sketch. 148.65KB Share 1AI Publication of pre-clinical trial of NTCELL in Parkinson's 16/09/13 PRICE SENSITIVE download Created with Sketch. 27.62KB Share 1AI Appendix 4E and Financial Statements 30/08/13 PRICE SENSITIVE download Created with Sketch. 648.48KB Share 1AI Preliminary Internal Review of Dia12 Study 27/08/13 PRICE SENSITIVE download Created with Sketch. 59.15KB Share 1AI Appendix 4C - quarterly 31/07/13 PRICE SENSITIVE download Created with Sketch. 114.03KB Share 1AI Appendix 4C - quarterly 29/04/13 PRICE SENSITIVE download Created with Sketch. 118.77KB Share 1AI Appendix 4D and Half-Year Accounts 27/02/13 PRICE SENSITIVE download Created with Sketch. 223.86KB Share 1AI Appendix 4C - quarterly 30/01/13 PRICE SENSITIVE download Created with Sketch. 66.79KB Share 1AI LCT & Otsuka to co-develop NTCELL for Parkinson's Disease 17/12/12 PRICE SENSITIVE download Created with Sketch. 119.44KB Share 1AI Strong interim results in Argentinian DIABECELL trial 22/11/12 PRICE SENSITIVE download Created with Sketch. 50.37KB Share 1AI LCT CEO Dr Andrea Grant appointed Managing Director 16/11/12 PRICE SENSITIVE download Created with Sketch. 41.42KB Share 1AI Ethical approval for LCT's NTCELL Phase I trial 16/11/12 PRICE SENSITIVE download Created with Sketch. 40.08KB Share 1AI Appendix 4C - quarterly 30/10/12 PRICE SENSITIVE download Created with Sketch. 98.21KB Share 1AI Authorisation of Ph1 trial of NTCell in Parkinsons Disease 04/10/12 PRICE SENSITIVE download Created with Sketch. 25.74KB Share 1AI LCT announces positive DIABECELL Phase I/IIa trial 26/09/12 PRICE SENSITIVE download Created with Sketch. 1.83MB Share 1AI Preliminary Final Report for the year ended 30 June 2012 29/08/12 PRICE SENSITIVE download Created with Sketch. 758.29KB Share 1AI Appendix 4C - quarterly 23/07/12 PRICE SENSITIVE download Created with Sketch. 100.63KB Share 1AI LCT's DIABECELL trial extension approved 17/05/12 PRICE SENSITIVE download Created with Sketch. 42.18KB Share 1AI Appendix 4C - quarterly 30/04/12 PRICE SENSITIVE download Created with Sketch. 56.65KB Share 1AI LCT Presents Novel Parkinson's Disease Treatment Results 21/03/12 PRICE SENSITIVE download Created with Sketch. 27.76KB Share 1AI LCT announces Share Purchase Plan 20/03/12 PRICE SENSITIVE download Created with Sketch. 30.32KB Share 1AI LCT granted E.U. Patent for tissue engineering 28/02/12 PRICE SENSITIVE download Created with Sketch. 26.18KB Share 1AI LCT completes pre-clinical studies of NTCELL in Parkinson's 28/02/12 PRICE SENSITIVE download Created with Sketch. 27.51KB Share 1AI Half Yearly Report and Accounts 28/02/12 PRICE SENSITIVE download Created with Sketch. 715.61KB Share 1AI Price query response 16/02/12 PRICE SENSITIVE download Created with Sketch. 61.79KB Share 1AI LCT granted USA Patent for Auckland Island Pigs 02/02/12 PRICE SENSITIVE download Created with Sketch. 27.94KB Share 1AI Appendix 4C - quarterly 27/01/12 PRICE SENSITIVE download Created with Sketch. 64.43KB Share 1AI LCT appoints Chief Executive 28/12/11 PRICE SENSITIVE download Created with Sketch. 25.37KB Share 1AI Settlement of $A50 million JV to commercialise DIABECELL 02/11/11 PRICE SENSITIVE download Created with Sketch. 78.08KB Share 1AI Appendix 4C - quarterly 28/10/11 PRICE SENSITIVE download Created with Sketch. 368.17KB Share 1AI Otsuka commits $A25 million to JV with LCT 19/10/11 PRICE SENSITIVE download Created with Sketch. 36.51KB Share 1AI Research collaboration with Centocor terminated 04/10/11 PRICE SENSITIVE download Created with Sketch. 25.4KB Share 1AI Preliminary Final Report 25/08/11 PRICE SENSITIVE download Created with Sketch. 762.76KB Share 1AI First Argentina Patients Implanted 22/08/11 PRICE SENSITIVE download Created with Sketch. 35.05KB Share 1AI Appendix 4C - quarterly 29/07/11 PRICE SENSITIVE download Created with Sketch. 67.31KB Share 1AI SpringTree facility terminated by mutual consent 26/07/11 PRICE SENSITIVE download Created with Sketch. 26.01KB Share 1AI LCT Enrols First Patients in DIABECELL Argentina Trial 27/06/11 PRICE SENSITIVE download Created with Sketch. 29.12KB Share 1AI Resignation and Appointment of acting CEO 24/06/11 PRICE SENSITIVE download Created with Sketch. 22.83KB Share 1AI SpringTree tranches paused until July 05/05/11 PRICE SENSITIVE download Created with Sketch. 22.37KB Share
0.9¢
(20min delay)
